Series Embark SERIES EMBARK
Here are some of the many stories about Kyoto-iCAP's relationship with the companies we support.
![#14 Paving the way for a sustainable future energy society with innovative energy storage technology](https://www.kyoto-unicap.co.jp/cms/wp-content/uploads/emberk_014.jpg)
CONNEXX SYSTEMS Co., Ltd.
![#13 "iPS Drug Discovery" searches for effective drugs for intractable<br> diseases for which there is no cure](https://www.kyoto-unicap.co.jp/cms/wp-content/uploads/emberk_013.jpg)
Stem Cell & Device Laboratory Inc.
![#10 iPS cell therapy aims to revolutionize treatment of chronic kidney disease (CKD)](https://www.kyoto-unicap.co.jp/cms/wp-content/uploads/embark_010.jpg)
Rege Nephro Co., Ltd.
![#06 Will it be the Main Axis of Next-Generation Energy? The Challenge of New Solar Cells](https://www.kyoto-unicap.co.jp/cms/wp-content/uploads/emberk_006.jpg)
EneCoat Technologies Co., Ltd.
![#05 Nurture university-originated drug discovery seeds and relay them to pharmaceutical companies](https://www.kyoto-unicap.co.jp/cms/wp-content/uploads/emberk_005.jpg)
Kyoto Drug Discovery & Development Co., Ltd.